Vascular Perfusion Abnormalities in Infants with Spinal Muscular Atrophy

Journal of Pediatrics

Volumn 155, Issue 2, 2009, Pages 292-294

  Araujo, Alexandra prufer de Queiroz Campos ^a   Araujo, Mario ^b   Swoboda, Kathryn J ^c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFECTIVE AGENT; DIOSMIN; HEPARIN; PENTOXIFYLLINE;

ANAMNESIS; ARTICLE; AUTONOMIC DYSFUNCTION; CASE REPORT; CLINICAL FEATURE; DOPPLER ECHOGRAPHY; FEMALE; FINGER MALFORMATION; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN TISSUE; INFANT; MUSCLE BIOPSY; PERFUSION; PRIORITY JOURNAL; SPINAL MUSCULAR ATROPHY;

ANTI-INFECTIVE AGENTS, LOCAL; ANTICOAGULANTS; ASPIRIN; DIOSMIN; FEMALE; FINGERS; HEPARIN; HUMANS; INFANT; NECROSIS; PENTOXIFYLLINE; PLATELET AGGREGATION INHIBITORS; SPINAL MUSCULAR ATROPHIES OF CHILDHOOD; TOES; VASODILATOR AGENTS;

EID: 67651083652     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.01.071     Document Type: Article

References (13)

1. Bach J.R. Medical considerations of long-term survival of Werdnig-Hoffmann disease. Am J Phys Med Rehabil 86 (2007) 349-355
2. Oskoui M., Levy G., Garland C.J., Gray J.M., O'Hagen J., and De Vivo D.C. The changing natural history of spinal muscular atrophy type 1. Neurology 69 (2007) 1931-1936
3. Narvar H.L., Kong L., Burnett B.G., Choe D.W., Bosch-Marce M., and Taye A.A. Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition. Ann Neurol 64 (2008) 465-470
4. Lambrechts D., and Carmeliet P. VEGF at the neurovascular interface: Therapeutic implications for motor neuron disease. Biochimica et Biophysica Acta 1762 (2006) 1109-1121
5. Dettmers C., Fatepour D., Faust H., and Jerusalem F. Sympathetic skin response abnormalities in amyotrophic lateral sclerosis. Muscle Nerve 16 (1993) 930-934
6. Marques V.D., Barreira A.A., Davis M.B., Abou-Sleiman P.M., Silva Jr. W.A., Zago M.A., et al. Expanding the phenotypes of the pro56ser VAPB mutation: proximal SMA with dysautonomia. Muscle Nerve 34 (2006) 731-739
7. Pisano F., Miscio G., Mazzuero G., Lanfranchi P., Colombo R., and Pinelli P. Decreased heart rate variability in amyotrophic lateral sclerosis. Muscle Nerve 18 (1995) 1225-1231
8. Rudnik-Schöneborn S., Stolz P., Varon R., Grohmann K., Schächtele M., Ketelsen U.P., et al. Long-term observations of infants with spinal muscular atrophy with respiratory distress type 1 (SMARD1). Neuropediatrics 35 (2004) 174-182
9. Shindo K., Tsunoda S., and Shiozawa Z. Increased sympathetic outflow to muscles in patients with amyotrophic lateral sclerosis: a comparison with other neuromuscular patients. J Neurol Sci 134 (1995) 57-60
10. Takahashi H., Oyanagi K., and Ikuta F. The intermediolateral nucleus in sporadic amyotrophic lateral sclerosis. Acta Neuropathol 86 (1993) 190-192
11. Arai H., Tanabe Y., Hachiya Y., Otsuka E., Kumada S., Furushima W., et al. Finger cold-induced vasodilatation, sympathetic skin response, and r-r interval variation in patients with progressive spinal muscular atrophy. J Child Neurol 20 (2005) 871-875
12. Kamiya A., Iwase S., Kitazawa H., Mano T., Vinogradova O.L., and Kharchenko I.B. Baroreflex control of muscle sympathetic nerve activity after 120 days of 6 degree head-down bed rest. Am J Physiol Regulatory Integrative Comp Physiol 278 (2000) R445-R452
13. Musch B.C., Papapetropoulos T.A., McQueen D.A., Hudgson P., and Weightman D. A comparison of the structure of small blood vessels in normal, denervated and dystrophic human muscle. J Neurol Sci 26 (1975) 221-234